spacer
home > pmps > winter 2002 > formulation integrated device systems for novel enhanced performance products
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Formulation Integrated Device Systems for Novel Enhanced Performance Products

The aim of developing formulation integrated device systems (FIDS) is to achieve enhanced performance from drugs, using technology that is aimed at solving specific biopharmaceutical, therapeutic, clinical or production problems. These patent-protected high performance systems are designed to provide better treatment outcomes and greater satisfaction for patients, whilst enabling new product development applications and enhanced ‘life cycle management’ opportunities for pharmaceutical companies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor John N Staniforth, Chief Scientific Officer at Vectura Ltd
Professor John N Staniforth PhD MRPharmS FZS CChem FRSC Churchill Fellow, is Chief Scientific Officer of Vectura, a pharmaceutical company specialising in novel pulmonary, oral and dermal technology and new product developments, based in the UK.

John has authored over 200 scientific publications in the area of pharmaceutical technology and is an Honorary Professor of the University of Bath. He is a Non-Executive Director of Penwest Pharmaceuticals Co Inc, New York, and a Founding Director of the drug delivery company, Phoqus Pharmaceuticals Ltd, UK.

spacer
Professor John N Staniforth
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisalaís world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement